Antibodies to Rods and Rings

Autoantibodies: Third Edition

Volumn , Issue , 2013, Pages 161-168

  Calise, S John ^a   Carcamo, Wendy C ^a   Ceribelli, Angela ^b,c   Dominguez, Yasmany ^a   Satoh, Minoru ^d,e   Chan, Edward K L ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

CTP; CTPS; GTP; Hepatitis C; IMPDH; IMPDH2; Interferon alpha; Ribavirin; Rods and rings

Indexed keywords

EID: 84902064621     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-444-56378-1.00019-8     Document Type: Chapter

References (9)

1. Carcamo W.C., Satoh M., Kasahara H., Terada N., Hamazaki T., Chan J.Y.F., et al. Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells. PLoS One 2011, 6. e29690.
2. Keppeke G.D., Nunes E., Ferraz M.L., Silva E.A., Granato C., Chan E.K.L., et al. Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-alpha. PLoS One 2012, 7. e45392.
3. Covini G., Carcamo W.C., Bredi E., von Muhlen C.A., Colombo M., Chan E.K.L. Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Antivir Ther 2012, 17:805-811.
4. Willingham M.C., Richert N.D., Rutherford A.V. A novel fibrillar structure in cultured cells detected by a monoclonal antibody. Exp Cell Res 1987, 171:284-295.
5. Seelig H.P., Appelhans H., Bauer O., Bluthner M., Hartung K., Schranz P., et al. Autoantibodies against inosine-5'-monophosphate dehydrogenase 2 - characteristics and prevalence in patients with HCV-infection. Clin Lab 2011, 57:753-765.
6. Wang J., Alexander P., Wu L., Hammer R., Cleaver O., McKnight S.L. Dependence of mouse embryonic stem cells on threonine catabolism. Science 2009, 325:435-439.
7. Carcamo W.C., Ceribelli A., Calise S.J., Krueger C., Liu C., Daves M., et al. Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients. J Clin Immunol 2013, 33:420-426.
8. Satoh M., Chan E.K.L., Ho L.A., Rose K.M., Parks C.G., Cohn R.D., et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 2012, 64:2319-2327.
9. Carcamo W.C., Yao B., Satoh M., Reeves W.H., Liu C., Covini G., et al. Cytoplasmic rings/rods as autoimmune targets of emerging human autoantibodies associated with HCV virus infection and interferon therapy. From Pathogenesis to Therapy of Autoimmune Diseases 2009, 127-134. Pabst Science Publishers, Lengerich, Germany. K. Conrad, E.K.L. Chan, M.J. Fritzler, R.L. Humbel, P. von Landenberg, Y. Shoenfeld (Eds.).